Abstract
Orthopedic implants are medical devices surgically placed into the body to replace a missing joint or bone or to reinforce a damaged structure. However, there is up to a 28% loosening rate on cementless implanted knee joint prostheses within a 4–10-year period after implant insertion, and a 2–5% infection rate for orthopedic implants (joint prostheses and fracture fixation devices). In the USA, total hip and knee arthroplasties currently account for over one million interventions each year. Due to the enormous size of the patient population with orthopedic implants, even a currently low risk of infection or failure has not only caused many patients to suffer, but it has also incurred huge costs for the associated health care system. Therefore, there is an urgent need to develop a novel dual-functional nanocoating technology with judiciously engineered physicochemical properties to address simultaneously the two critical issues long facing orthopedic implants: lack of integration with bone tissue and biofilm-caused infections for the enhanced success of implants.
We have generated a nanocoating showing a very promising capability of inhibiting biofilm formation by Staphylococcus aureus and Staphylococcus epidermidis, two of the most common biofilm formers on orthopedic implants, and enhancing bone conductivity simultaneously. The dual-functional nanocoatings coming out of our research demonstrated the following unique features for orthopedic implants: (1) inhibit bacterial colonization and concomitantly promote osteoblast functions; (2) generate long-lasting functionalities for practical clinical applications because these nanocoatings are dense and highly cross-linked without substances of low molecular weight; (3) provide needed abrasion resistance for orthopedic implants and ensure strong coating adhesion to the surface; and (4) improve bone integration and reduce device-related infections in the long run.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Davies D (2003) Understanding biofilm resistance to antibacterial agents. Nat Rev Drug Discov 2:114–122
Donlan RM (2001) Biofilms and device-associated infections. Emerg Infect Dis 7:277–281
Campoccia D, Montanaro L, Arciola CR (2006) The significance of infection related to orthopedic devices and issues of antibiotic resistance. Biomaterials 27(11):2331–2339
Zaborowska M, Tillander J, Brånemark R, Hagberg L, Thomsen P, Trobos M (2017) Biofilm formation and antimicrobial susceptibility of staphylococci and enterococci from osteomyelitis associated with percutaneous orthopaedic implants. J Biomed Mater Res B Appl Biomater 105(8):2630–2640
Li B, Webster TJ (2018) Bacteria antibiotic resistance: new challenges and opportunities for implant-associated orthopedic infections. J Orthop Res 36(1):22–32
Donlan RM, Costerton JW (2002) Biofilms: survival mechanisms of clinically relevant microorganisms. Clin Microbiol Rev 15:167–193
Darouiche RO (2004) Treatment of infections associated with surgical implants. N Engl J Med 350:1422–1429
Steiner C, Andrews R, Barrett M, Weiss A (2012) HCUP Projections: Mobility/Orthopedic Procedures 2003 to 2012. HCUP Projections Report # 2012-03. 2012 Sep 20. U.S. Agency for Healthcare Research and Quality. http://hcup-us.ahrq.gov/reports/projections/2012-03.pdf. Accessed 12 Apr 2019
Kurtz S, Ong K, Lau E, Mowat F, Halpern M (2007) Projections of primary and revision hip and knee arthroplasty in the United States from 2005 to 2030. J Bone Joint Surg Am 89:780–785
Kremers HM, Larson DR, Crowson CS, Kremers WK, Washington RE, Steiner CA, Jiranek WA, Berry DJ (2015) Prevalence of total hip and knee replacement in the United States. J Bone Joint Surg Am 97(17):1386–1397
Antoci V Jr et al (2008) The inhibition of Staphylococcus epidermidis biofilm formation by vancomycin-modified titanium alloy and implications for the treatment of periprosthetic infection. Biomaterials 29:4684–4690
Lucke M et al (2003) Gentamicin coating of metallic implants reduces implant-related osteomyelitis in rats. Bone 32:521–531
Popat KC, Eltgroth M, LaTempa TJ, Grimes CA, Desai TA (2007) Decreased Staphylococcus epidermis adhesion and increased osteoblast functionality on antibiotic-loaded titania nanotubes. Biomaterials 28:4880–4888
Sampath LA, Tambe SM, Modak SM (2001) In vitro and in vivo efficacy of catheters impregnated with antiseptics or antibiotics: evaluation of the risk of bacterial resistance to the antimicrobials in the catheters. Infect Control Hosp Epidemiol 22:640–646
Tambe SM, Sampath L, Modak SM (2001) In vitro evaluation of the risk of developing bacterial resistance to antiseptics and antibiotics used in medical devices. J Antimicrob Chemother 47:589–598
Jiang H, Manolache S, Wong ACL, Denes FS (2004) Plasma-enhanced deposition of silver nanoparticles onto polymer and metal surfaces for the generation of antimicrobial characteristics. J Appl Polym Sci 93:1411–1422
Stobie N et al (2008) Prevention of Staphylococcus epidermidis biofilm formation using a low-temperature processed silver-doped phenyltriethoxysilane sol-gel coating. Biomaterials 29:963–969
Zeng X, Xiong S, Zhuo S, Liu C, Miao J, Liu D, Wang H, Zhang Y, Zheng Z, Ting K, Wang C, Liu Y (2019) Nanosilver/poly (dl-lactic-co-glycolic acid) on titanium implant surfaces for the enhancement of antibacterial properties and osteoinductivity. Int J Nanomedicine 14:1849–1863
Rai M, Yadav A, Gade A (2009) Silver nanoparticles as a new generation of antimicrobials. Biotechnol Adv 27:76–83
Baveja JK et al (2004) Furanones as potential anti-bacterial coatings on biomaterials. Biomaterials 25:5003–5012
Hume EB et al (2004) The control of Staphylococcus epidermidis biofilm formation and in vivo infection rates by covalently bound furanones. Biomaterials 25:5023–5030
Klibanov AM (2007) Permanently microbicidal materials coatings. J Mater Chem 17:2479–2482
Harris LG, Tosatti S, Wieland M, Textor M, Richards RG (2004) Staphylococcus aureus adhesion to titanium oxide surfaces coated with non-functionalized and peptide-functionalized poly(L-lysine)-grafted-poly(ethylene glycol) copolymers. Biomaterials 25:4135–4148
Cheng G, Zhang Z, Chen S, Bryers JD, Jiang S (2007) Inhibition of bacterial adhesion and biofilm formation on zwitterionic surfaces. Biomaterials 28:4192–4199
Privett BJ et al (2011) Antibacterial fluorinated silica colloid superhydrophobic surfaces. Langmuir 27:9597–9601
Xu LC, Siedlecki CA (2012) Submicron-textured biomaterial surface reduces staphylococcal bacterial adhesion and biofilm formation. Acta Biomater 8:72–81
Chien CY, Liu TY, Kuo WH, Wang MJ, Tsai WB (2013) Dopamine-assisted immobilization of hydroxyapatite nanoparticles and RGD peptides to improve the osteoconductivity of titanium. J Biomed Mater Res A 101:740–747
Wang G, Zreiqat H (2010) Functional coatings or films for hard-tissue applications. Materials 3:3994–4050
Wang Y, Liu X, Fan T, Tan Z, Zhou Z, He D (2017) In vitro evaluation of hydroxyapatite coatings with (002) crystallographic texture deposited by micro-plasma spraying. Mater Sci Eng C Mater Biol Appl 75:596–601
Łukaszewska-Kuska M, Krawczyk P, Martyla A, Hędzelek W, Dorocka-Bobkowska B (2018) Hydroxyapatite coating on titanium endosseous implants for improved osseointegration: physical and chemical considerations. Adv Clin Exp Med 27(8):1055–1059
Oosterbos CJ et al (2002) Osseointegration of hydroxyapatite-coated and noncoated Ti6Al4V implants in the presence of local infection: a comparative histomorphometrical study in rabbits. J Biomed Mater Res 60:339–347
Vogely HC et al (2000) Effects of hydrosyapatite coating on Ti-6A1-4V implant-site infection in a rabbit tibial model. J Orthop Res 18:485–493
Neoh KG, Hu X, Zheng D, Kang ET (2012) Balancing osteoblast functions and bacterial adhesion on functionalized titanium surfaces. Biomaterials 33:2813–2822
Zhang F, Zhang Z, Zhu X, Kang ET, Neoh KG (2008) Silk-functionalized titanium surfaces for enhancing osteoblast functions and reducing bacterial adhesion. Biomaterials 29:4751–4759
Maddikeri RR, Tosatti S, Schuler M, Chessari S, Textor M, Richards RG et al (2008) Reduced medical infection related bacterial strains adhesion on bioactive RGD modified titanium surfaces: a first step toward cell selective surfaces. J Biomed Mater Res A 84:425–435
Subbiahdoss G et al (2010) Bacterial biofilm formation versus mammalian cell growth on titanium-based mono- and bi-functional coating. Eur Cell Mater 19:205–213
Chua PH, Neoh KG, Kang ET, Wang W (2008) Surface functionalization of titanium with hyaluronic acid/chitosan polyelectrolyte multilayers and RGD for promoting osteoblast functions and inhibiting bacterial adhesion. Biomaterials 29:1412–1421
Shi Z, Neoh KG, Kang ET, Poh C, Wang W (2008) Bacterial adhesion and osteoblast function on titanium with surface-grafted chitosan and immobilized RGD peptide. J Biomed Mater Res A 86:865–872
Shi Z, Neoh KG, Kang ET, Poh C, Wang W (2009) Titanium with surface-grafted dextran and immobilized bone morphogenetic protein-2 for inhibition of bacterial adhesion and enhancement of osteoblast functions. Tissue Eng Part A 15:417–426
Shi Z, Neoh KG, Kang ET, Poh CK, Wang W (2009) Surface functionalization of titanium with carboxymethyl chitosan and immobilized bone morphogenetic protein-2 for enhanced osseointegration. Biomacromolecules 10:1603–1611
Hu X et al (2010) An in vitro assessment of titanium functionalized with polysaccharides conjugated with vascular endothelial growth factor for enhanced osseointegration and inhibition of bacterial adhesion. Biomaterials 31:8854–8863
Ratner BD (1997) Plasma processing of polymers. In: d’Agostino R, Favia P, Fracassi F (eds) . Kluwer Academic Publishers, Dordrecht, The Netherlands
Lerouge S, Major A, Girault-Lauriault PL, Raymond MA, Laplante P, Soulez G et al (2007) Nitrogen-rich coatings for promoting healing around stent-grafts after endovascular aneurysm repair. Biomaterials 28:1209–1217
Chen M, Osaki S, Zamora PO, Potekhin M (2003) Effect of nitrogen and oxygen incorporated into TMSAA plasma coating on surface-bound heparin activity. J Appl Polym Sci 89:1875–1883
Shen Y et al (2009) Investigation of surface endothelialization on biomedical nitinol (NiTi) alloy: effects of surface micropatterning combined with plasma nanocoatings. Acta Biomater 5:3593–3604
Tang CJ et al (2010) A study on surface endothelialization of plasma coated intravascular stents. Surf Coat Technol 204:1487–1492
Jones JE, Yu Q, M Chen M (2017) A chemical stability study of trimethylsilane plasma nanocoatings for coronary stents. J Biomater Sci Polym Ed 28(1):15–32
Stallard CP, McDonnell KA, Onayemi OD, O'Gara JP, Dowling DP (2012) Evaluation of protein adsorption on atmospheric plasma deposited coatings exhibiting superhydrophilic to superhydrophobic properties. Biointerphases 7:31
Ma Y et al (2012) Inhibition of Staphylococcus epidermidis biofilm by trimethylsilane plasma coating. Antimicrob Agents Chemother 56:5923–5937
Yang Y, Kulangara K, Lam RT, Dharmawan R, Leong KW (2012) Effects of topographical and mechanical property alterations induced by oxygen plasma modification on stem cell behavior. ACS Nano 6:8591–8598
Lee JT et al (2011) Cell culture medium as an alternative to conventional simulated body fluid. Acta Biomater 7:2615–2622
Cassat JE, Lee CY, Smeltzer MS (2007) Investigation of biofilm formation in clinical isolates of Staphylococcus aureus. Methods Mol Biol 391:127–144
Niska JA et al (2012) Monitoring bacterial burden, inflammation and bone damage longitudinally using optical and muCT imaging in an orthopaedic implant infection in mice. PLoS One 7:e47397
Niska JA et al (2013) Vancomycin-rifampin combination therapy has enhanced efficacy against an experimental Staphylococcus aureus prosthetic joint infection. Antimicrob Agents Chemother 57:5080–5086
Niska JA et al (2012) Daptomycin and tigecycline have broader effective dose ranges than vancomycin as prophylaxis against a Staphylococcus aureus surgical implant infection in mice. Antimicrob Agents Chemother 56:2590–2597
Bernthal NM et al (2010) A mouse model of post-arthroplasty Staphylococcus aureus joint infection to evaluate in vivo the efficacy of antimicrobial implant coatings. PLoS One 5:e12580
Xu Y et al (2015) Nanoscale plasma coating inhibits formation of Staphylococcus aureus biofilm. Antimicrob Agents Chemother 59(12):7308–7315
Wu S et al (2011) Plasma-modified biomaterials for self-antimicrobial applications. ACS Appl Mater Interfaces 3:2851–2860
Ma Y et al (2012) Novel inhibitors of Staphylococcus aureus virulence gene expression and biofilm formation. PLoS One 7:e47255
Thevenot P et al (2008) Surface chemistry influence implant biocompatibility.Curr Top Med Chem 8(4): 270–280
Cheung AL, Fischetti VA (1990) The role of fibrinogen in staphylococcal adherence to catheters in vitro. J Infect Dis 161:1177–1186
Pei L, Flock JI (2001) Lack of fbe, the gene for a fibrinogen-binding protein from Staphylococcus epidermidis, reduces its adherence to fibrinogen coated surfaces. Microb Pathog 31:185–193
Acknowledgments
Some of the research results presented in this entry were generated from the project funded by the National Heart, Lung, and Blood Institute (NHLBI) of the NIH, grant R44HL097485 and NIH grant P01HL573461. The authors are grateful for the contributions of all colleagues and collaborators in this research area of nanocoating technology for orthopedic implant application. We are also thankful for the thoughtful and constructive comments and suggestions of the reviewers, which have improved the presentation.
Conflict of interest: Dr. Hongmin Sun owns stocks in Nanova, Inc. This does not detract from an author’s objectivity in presentation of study results.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2020 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Chen, M. et al. (2020). Biofilm-inhibiting and Osseointegration-promoting Orthopedic Implants with Novel Nanocoatings. In: Li, B., Moriarty, T., Webster, T., Xing, M. (eds) Racing for the Surface. Springer, Cham. https://doi.org/10.1007/978-3-030-34471-9_3
Download citation
DOI: https://doi.org/10.1007/978-3-030-34471-9_3
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-34470-2
Online ISBN: 978-3-030-34471-9
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)